NCT04130685View on ClinicalTrials.gov

Donor-Derived Cell-Free DNA for Surveillance in Simultaneous Pancreas and Kidney Transplant Recipients

CompletedOBSERVATIONAL
Enrollment

48

Participants

Timeline

Start Date

January 15, 2020

Primary Completion Date

May 31, 2021

Study Completion Date

December 1, 2022

Conditions
Pancreas Transplant RejectionKidney Transplant Rejection
Interventions
DIAGNOSTIC_TEST

Allosure Test

Venous Blood Draw

Trial Locations (1)

60612

Rush University Medical Center, Chicago

Sponsors

Collaborators (1)

CareDx
All Listed Sponsors
collaborator

CareDx

INDUSTRY

lead

Rush University Medical Center

OTHER

NCT04130685 - Donor-Derived Cell-Free DNA for Surveillance in Simultaneous Pancreas and Kidney Transplant Recipients | Biotech Hunter | Biotech Hunter